Xinan Cen

702 total citations
61 papers, 406 citations indexed

About

Xinan Cen is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Xinan Cen has authored 61 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 17 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Xinan Cen's work include Hematopoietic Stem Cell Transplantation (13 papers), Lymphoma Diagnosis and Treatment (12 papers) and Multiple Myeloma Research and Treatments (11 papers). Xinan Cen is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Lymphoma Diagnosis and Treatment (12 papers) and Multiple Myeloma Research and Treatments (11 papers). Xinan Cen collaborates with scholars based in China, United States and Romania. Xinan Cen's co-authors include Yini Wang, Zhao Wang, Liangding Hu, Na Wei, Jijun Wang, Jianliang Shen, Lihong Li, Yujun Dong, Hanyun Ren and Zeyin Liang and has published in prestigious journals such as Blood, British Journal of Haematology and BMC Cancer.

In The Last Decade

Xinan Cen

51 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinan Cen China 9 230 165 155 105 97 61 406
Tadaharu Kanie Japan 10 157 0.7× 108 0.7× 132 0.9× 62 0.6× 33 0.3× 22 369
Stéphanie Nguyen Quoc France 9 91 0.4× 129 0.8× 230 1.5× 131 1.2× 40 0.4× 14 422
Michihiko Masuda Japan 12 175 0.8× 98 0.6× 117 0.8× 86 0.8× 33 0.3× 27 375
Byoung Kook Kim South Korea 12 192 0.8× 84 0.5× 135 0.9× 93 0.9× 20 0.2× 43 410
Sandeep Nagra United Kingdom 13 351 1.5× 134 0.8× 143 0.9× 45 0.4× 35 0.4× 21 518
Ian H Gabriel United Kingdom 7 146 0.6× 177 1.1× 85 0.5× 98 0.9× 23 0.2× 14 399
Sergey N. Bondarenko Russia 9 335 1.5× 144 0.9× 112 0.7× 27 0.3× 35 0.4× 117 466
R Hanada Japan 7 199 0.9× 99 0.6× 109 0.7× 38 0.4× 86 0.9× 8 352
Meiqing Wu China 10 256 1.1× 86 0.5× 134 0.9× 44 0.4× 36 0.4× 40 442

Countries citing papers authored by Xinan Cen

Since Specialization
Citations

This map shows the geographic impact of Xinan Cen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinan Cen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinan Cen more than expected).

Fields of papers citing papers by Xinan Cen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinan Cen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinan Cen. The network helps show where Xinan Cen may publish in the future.

Co-authorship network of co-authors of Xinan Cen

This figure shows the co-authorship network connecting the top 25 collaborators of Xinan Cen. A scholar is included among the top collaborators of Xinan Cen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinan Cen. Xinan Cen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mu, Guangyan, et al.. (2024). Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review). International Journal of Molecular Medicine. 53(6). 4 indexed citations
2.
3.
Xie, Weiwei, et al.. (2022). Clinical Characteristics and Prognosis of Multiple Myeloma With Myelomatous Pleural Effusion: A Retrospective Single-Center Study. Technology in Cancer Research & Treatment. 21. 2213874258–2213874258. 4 indexed citations
4.
Shen, Ye, et al.. (2022). Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma. International Journal of Medical Sciences. 19(2). 225–232. 8 indexed citations
5.
6.
Yong, Zi-hao, Xiaojuan Yu, Fude Zhou, et al.. (2021). Myeloma cast nephropathy with diffuse amyloid casts without systemic amyloidosis: two cases report. BMC Nephrology. 22(1). 6–6.
7.
Zhang, Xu, et al.. (2021). Monoclonal Immunoglobulin-Associated Renal Lesions in Patients with Newly Diagnosed Multiple Myeloma: A Report from a Single Center. Cancer Management and Research. Volume 13. 3879–3888. 3 indexed citations
8.
Lu, Jin, Weijun Fu, Wei Li, et al.. (2021). Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study. Clinical Lymphoma Myeloma & Leukemia. 21(9). e699–e709. 23 indexed citations
9.
Shen, Ye, et al.. (2021). Influence of Severe Gastrointestinal Complications in Primary Gastrointestinal Diffuse Large B-Cell Lymphoma. Cancer Management and Research. Volume 13. 1041–1052. 7 indexed citations
10.
Xiang, Qian, Zhiyan Liu, Yanyan Yu, et al.. (2020). Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report. BMC Pharmacology and Toxicology. 21(1). 43–43. 2 indexed citations
11.
12.
Yang, Haiyan, Ye Shen, Lan Mi, et al.. (2019). Treatment Strategies and Prognostic Factors of Primary Gastric Diffuse Large B Cell Lymphoma: A Retrospective Multicenter Study of 272 Cases from the China Lymphoma Patient Registry. International Journal of Medical Sciences. 16(7). 1023–1031. 11 indexed citations
13.
14.
15.
Wang, Yini, Rui Zhang, Huyong Zheng, et al.. (2015). [A multicenter retrospective etiological analysis of 601 patients with hemophagocytic lymphohistiocytosis in China].. PubMed. 54(12). 1018–22. 6 indexed citations
16.
Dong, Yujun, Mingyue Wang, Lin Nong, et al.. (2015). Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor. British Journal of Haematology. 169(6). 834–842. 63 indexed citations
17.
Wang, Meng, Yujun Dong, Wei Liu, et al.. (2014). HLA Disparity is not crucial for the survival rate and severity of chronic health conditions in adult recipients following family donor hematopoietic stem cell transplantation. International Journal of Hematology. 101(1). 75–82. 10 indexed citations
18.
Wang, Zhao, Yini Wang, Liangding Hu, et al.. (2014). Hemophagocytic Lymphohistiocytosis Is Not Only a Childhood Disease: A Multi-Center Study of 613 Cases from Chinese HLH Workgroup. Blood. 124(21). 4146–4146. 3 indexed citations
19.
Liu, Wei, Hanyun Ren, Yujun Dong, et al.. (2012). Bortezomib regulates the chemotactic characteristics of T cells through downregulation of CXCR3/CXCL9 expression and induction of apoptosis. International Journal of Hematology. 96(6). 764–772. 15 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tadaharu Kanie Breakdown of academic impact, for papers by Stéphanie Nguyen Quoc Breakdown of academic impact, for papers by Michihiko Masuda Breakdown of academic impact, for papers by Byoung Kook Kim Breakdown of academic impact, for papers by Sandeep Nagra Breakdown of academic impact, for papers by Ian H Gabriel Breakdown of academic impact, for papers by Sergey N. Bondarenko Breakdown of academic impact, for papers by R Hanada Breakdown of academic impact, for papers by Meiqing Wu
Rankless by CCL
2026